Holen Sie sich die Stockscreener-App
11.60
9.02%
-1.15
Handel nachbörslich:
11.00
-0.60
-5.17%
Schlusskurs vom Vortag:
$12.75
Offen:
$12.64
24-Stunden-Volumen:
13,094
Relative Volume:
0.36
Marktkapitalisierung:
$7.83M
Einnahmen:
$43.86M
Nettoeinkommen (Verlust:
$-37.43M
KGV:
-5.7505
EPS:
-2.0172
Netto-Cashflow:
$-12.50M
1W Leistung:
+37.36%
1M Leistung:
-0.55%
6M Leistung:
-52.62%
1J Leistung:
-43.63%
1-Tages-Spanne:
$11.58
$12.64
1-Wochen-Bereich:
$7.94
$14.17
52-Wochen-Spanne:
$7.94
$103.20
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Firmenname
Trinity Biotech Plc Adr
Sektor
Branche
Telefon
-
Adresse
-
Compare TRIB vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
11.60 | 6.18M | 43.86M | -37.43M | -12.50M | -2.0172 |
ABT
Abbott Laboratories
|
105.74 | 182.00B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
325.74 | 129.09B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
85.40 | 107.81B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
46.73 | 67.64B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.03 | 47.81B | 6.30B | 1.07B | 1.09B | 1.8406 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2015-10-23 | Herabstufung | Craig Hallum | Buy → Hold |
| 2015-09-03 | Eingeleitet | Raymond James | Outperform |
| 2015-07-29 | Bestätigt | ROTH Capital | Buy |
| 2008-07-22 | Bestätigt | Roth Capital | Buy |
| 2008-03-17 | Bestätigt | Roth Capital | Buy |
| 2007-12-10 | Bestätigt | Roth Capital | Buy |
| 2007-10-26 | Bestätigt | Roth Capital | Buy |
Alle ansehen
Trinity Biotech Plc Adr Aktie (TRIB) Neueste Nachrichten
TRIB,ZBRA Volatility & Greeks - Finviz
Trinity Biotech plc Sponsored ADR Revenue Breakdown – FWB:TRB0 - TradingView
Trinity Biotech plc (TRIB) stock price, news, quote and history - Yahoo Finance UK
Trinity Biotech partners with Latch Medical on metabolic health tech - Investing.com
These stocks are moving in today's pre-market session - ChartMill
Trinity Biotech plans 1-for-30 reverse ADS split - Investing.com
Trinity Biotech Plc Announces Plan to Implement ADS Ratio Change - Yahoo Finance
Price to book forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Enterprise value to EBIT forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Price to earnings forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Price to sales forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Enterprise value to revenue forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
Enterprise value to EBITDA forward of Trinity Biotech plc Sponsored ADR – FWB:TRB0 - TradingView
TRINITY BIOTECH PLC-SPON ADR (TRIB) Stock Chart - ChartMill
Trinity Biotech CGM+ detects false low glucose alerts during sleep - Investing.com
TRIBTrinity Biotech Plc ADR Volatility & Greeks - Finviz
Trinity Biotech unit secures OCP membership for AI cooling - Investing.com
Trinity Biotech unit secures OCP membership for AI cooling By Investing.com - Investing.com India
Trinity Biotech Plc Sponsored ADR Class A Actuals & Estimates (NASDAQ:TRIB) - TradingView
The market is filled with gapping stocks in Tuesday's session. - ChartMill
Form 6K Trinity Biotech plc For: 23 June By Investing.com - Investing.com South Africa
Trinity Biotech launches liquid cooling subsidiary Trinovium - Investing.com
Trinity Biotech announces orders for over 2 million HIV tests and Q1 results By Investing.com - Investing.com South Africa
Trinity Biotech announces orders for over 2 million HIV tests and Q1 results - Investing.com
Number of shareholders of Trinity Biotech plc ADR – FWB:TRB0 - TradingView
Trinity Biotech (TRIB) 10K Form and Latest SEC Filings 2026 - MarketBeat
Trinity Biotech names Jerry Lydon head of North America operations - Investing.com
New LowStock ScreenerSnapshot - Finviz
Trinity Biotech plc Stock: Navigating Challenges in the Diagnostics Sector Amid Market Volatility - AD HOC NEWS
Trinity Biotech reports clinical study results for prostate test By Investing.com - Investing.com South Africa
Trinity Biotech reports clinical study results for prostate test - Investing.com
ADR Ratio Change - Yahoo Finance
Trinity Biotech advances CGM+ device toward pivotal trial - Investing.com
Trinity Biotech secures $25M equity financing facility - Investing.com
Trinity Biotech secures $25M equity financing facility By Investing.com - Investing.com South Africa
Trinity Biotech receives Nasdaq delisting warning notice - Investing.com
Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares - GlobeNewswire Inc.
Trinity Biotech receives final approval for HIV test manufacturing shift - Investing.com India
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification By Investing.com - Investing.com South Africa
Trinity Biotech’s HbA1c analyzer achieves IFCC gold classification - Investing.com
Trinity Biotech stock soars after major HIV test order signals market recovery - Investing.com
Trinity Biotech expands rollout of next-gen HbA1c testing system - Investing.com
Trinity Biotech (TRIB) FDA Approvals, PDUFA Dates & Drug Alerts 2026 $TRIB - MarketBeat
India Hba1c Testing Devices Market Size & Outlook, 2024-2030 - Grand View Research
UK Blood Testing Market Size & Outlook, 2025-2030 - Grand View Research
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested - TipRanks
Trinity Biotech appoints Paul Tivnan to board of directors - Investing.com
Trinity Biotech receives approval for offshore manufacturing of HIV test - Investing.com
Should I buy Trinity Biotech (TRIB) - Zacks Investment Research
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test - Investing.com
Trinity Biotech reports positive results for calibration-free CGM - Investing.com
Finanzdaten der Trinity Biotech Plc Adr-Aktie (TRIB)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
11.95%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):